Abstract. GABA A receptors are heteropentameric ligand-gated chloride channels composed of a variety of subunits, including α1 -6, β1 -3, γ1 -3, δ, ε, θ, and π, and play a key role in controlling inhibitory neuronal activity. Modification of the efficacy of the synaptic strength is produced by changes in both the number of neuronal surface receptors and pentameric molecular assembly, leading to differences of sensitivity to neurotransmitters and neuromimetic drugs. Therefore, it is important to understand the molecular mechanisms regulating the so-called "life cycle of GABA A receptors" including sequential pentameric assembly at the site synthesized, intracellular transport through the Golgi apparatus and the cytoplasm, insertion into the cell membrane, functional modulation at the cell surface, and finally internalization, followed by either recycling back to the surface membrane or lysosomal degradation. This review is focused on events related to the surface expression of the receptor containing the γ2 subunit and clathrin / AP2 complex-mediated phospho-regulated endocytosis of the receptor, with special reference to the function of novel GABA A receptor modulators, GABARAP (GABA A receptorassociated protein) and PRIP (phospholipase C-related, but catalytically inactive protein).
Fast synaptic inhibition in the central nervous system is mediated predominantly by type A γ-aminobutyric acid (GABA) receptors, which constitute GABA-gated heteromeric chloride ion channels. GABA A receptors are also major targets for clinically relevant drugs such as benzodiazepines (BZ), barbiturates, alcohol, and general anesthetics, since modulation of the receptor functions by the drugs contributes to the regulation of several types of disorders related to the central nervous system. GABA A receptors are heteropentamers composed of subunits including α1 -6, β1 -3, γ1 -3, δ, ε, θ, and π. Although a vast number of heteropentameric combinations are theoretically possible, the majority of the receptors present in the central nervous system are composed of α, β, and γ subunits with the ratio of 2:2:1, and it is said that there are approximately 20 native combinations in the mammalian brain (Fig. 1A) . Each subunit of a GABA A receptor is composed of about 500 amino acids and has a similar membrane topology (for review, see ref. 1) . As shown in Fig. 1B , there is a large amino-terminal domain that is believed to accommodate a neurotransmitter (GABA) or many of the drugs described above, followed by four hydrophobic membrane-spanning domains, with third and fourth domains divided by a large loop composed of about 125 amino acids. This loop is the most divergent region in the amino acid sequence among the individual receptor sub-units, and it provides specific serine / threonine or tyrosine residues for phosphorylation by a variety of kinases and contains the regions for associating with many protein molecules for modulation of receptor fates and functions. Studies of the functional significance of the associating proteins provide important clues for understanding the mechanisms regulating GABA A receptors' fates and activities (for review, see ref.
2).
The receptor characteristics largely depend on the subunit composition of individual GABA A receptors (1) . In particular, the inclusion of a γ2 subunit in the pentamer is essential to make receptors sensitive to BZtype drugs, which are widely used for anxiolytic, hypnotic, anticonvulsant, and muscle-relaxing actions. The contribution of each subunit to the receptor function has been studied using gene targeting methodology (for review, see ref. 1). Gene knockout of the α1 or β2 subunit caused neither a lethal phenotype nor epileptic seizures, although the number of GABA A receptors on the surface membrane was reduced to 50% (3). On the other hand, targeted disruption of the γ2 subunit gene caused 94% reduction of the BZ sites, as expected, and caused a perinatally lethal phenotype in the majority of mutant mice (4) . Most of the β3 subunit knockout mice also died in the neonatal period (5) . Therefore, the presence of these two subunits, β3 and γ2, at specific brain regions (6) , is absolutely required for GABA A receptors to function in maintaining animal life itself, while modulation of the composition of other subunits causes changes in the functional characteristics of GABA A receptors.
Many studies have been carried out to clarify the molecular mechanisms underlying the control of not only the number of receptors on the neuronal membranes, but also the subunit composition, particularly whether the receptors contain the γ subunits or not, because this subunit is the target of BZ-drugs (4). Because of space limitations, this review is focused on two issues related to the regulation of GABA A receptors, with special reference to the function of GABARAP and PRIP: that is, γ2 subunit trafficking controlling the receptor characteristics and endocytosis of GABA A receptors controlling the surface receptor numbers.
GABARAP (GABA A receptor-associated protein), a modulator of trafficking of GABA A receptors containing the γ2 subunit
The assembly and delivery of multiple GABA A -receptor subtypes in neurons requires sophisticated control steps at the level of assembly and sorting into distinct trafficking vesicles as well as regulated and directed transport to their final destination. Recently, a number of reports have been published regarding the GABA A receptor intracellular loop-associated molecules involved in the dynamic regulation of GABA A -receptor trafficking (for review, see ref.
2). Among those, GABARAP is the best studied (2, 7 -9) .
GABARAP, a γ2 subunit intracellular loop-associated protein cloned in a yeast two-hybrid experiment, is a 17-kDa polypeptide that interacts specifically with the major intracellular domains of receptor γ1, γ2S, and γ2L subunits (the binding region: amino acid residues 35 -52 of GABARAP) and is also capable of interacting with microtubules (the binding region: amino acid residues 1 -22 of GABARAP) (7) . GABARAP is a member of a protein family including GEC1 (or GABARAPL1), the Golgi-associated ATPase enhancer of 16 kDa (GATE-16), the yeast orthologue Apg8 / Aut7 (which are all highly homologous members), and the A: Heteropentameric GABAA receptors forming Cl − channels. Binding of a neurotransmitter triggers a small rotation of the extracellular domains of the receptor subunits, resulting in opening of the channel pore formed by the adjoining TM2 regions of the five subunits. A receptor composed of α:β:γ subunits in the ratio 2:2:1, a prevalent form in the brain, is represented. GABA binds the interface of α/β subunits. B: Subunit structure of GABAA receptors with four transmembrane domains and extracellular N-and C-termini. The large amino-terminal domain located extracellularly is believed to accommodate neurotransmitter (GABA) and some modulator chemicals. TM2 forms the lining of the ion channel. The intracellular loop region between TM3 and TM4 is the most divergent part of individual receptor subunits and contains phosphorylation sites [S409 (β1), S410 (β2), S408 /409 (β3), S327 (γ2S), S343 (γ2L), Y365/367 (γ2)] for both serine /threonine and tyrosine kinases. Examples of intracellular loop-associated proteins include the following: GABARAP (γ1 -3), PRIP (β1 -3), µ2 subunit of AP2 (β1 -3, γ2, δ), GODZ (γ2), BIG2 (β1 -3), Plic-1 (α2, α3, α6, β1 -3), HAP1 (β1), Src (β1, γ2), and RACK1 (α1, β1). Molecules described in this review are underlined.
microtubule-associated protein light chain 3 (MAP-LC3), a less similar member of the family. Interestingly, all the proteins of the family are involved in intracellular trafficking events (for review, see ref.
2), and in particular, GEC1 has recently been shown to be involved in κ opioid receptor surface expression (10) .
GABARAP was first identified as the molecule responsible for clustering of GABA A receptors at the postsynaptic membranes (7). However, GABARAP does not appear to co-localize extensively with the surface GABA A receptor, and instead, it predominantly co-localizes with the γ2 subunit in the cytoplasmic perinuclear region in hippocampal neurons (8, 11) . Furthermore, recent gene-knock out experiments of GABARAP in mice indicate no impairment in receptor clustering, indicating that GABARAP may not be involved in receptor clustering (12) . However, it is still possible that GABARAP is involved in receptor clustering, but that its involvement is obscured by redundancy: that is, the homologues of GABARAP compensate for the function of GABARAP in the mutant mice. GEC1 is a potent candidate for such an effect, because the region of γ2 subunit binding in GABARAP (amino acids 35 -52) is highly conserved in GEC1 (16 out of 18 amino acids) (10) . Alternatively, GABARAP might play an important role in the trafficking and surface expression of receptors containing the γ2 subunit, since GABARAP also associates directly with N-ethylmaleimide-sensitive factor (NSF), a protein that plays a central role in general membrane fusion events during intracellular trafficking processes (11) .
A pivotal role of GABARAP in the regulation of GABA A -receptor activities has been experimentally elucidated: GABARAP is a key player in the trafficking of these receptors, especially those containing the γ2 subunit, to the cell surface membrane. Recent studies further revealed that GABARAP enhances the cell surface expression of γ2 subunit-containing GABA A receptors in both a reconstituted cellular expression system and cultured hippocampal neurons (8) . Exogenous expression of GABARAP along with the α, β, and γ subunits of GABA A receptors in Xenopus laevis oocytes resulted in increased GABA currents and surface-expressed receptor molecules (9) .
It could be assumed that GABARAP increases either the trafficking of vesicles containing the receptors in the Golgi network and in the cytoplasm toward the cell membrane along tracks of microtubules or facilitates their insertion or stabilizes the surface receptors, or all of these events. However, the precise molecular mechanisms underlying GABARAP-dependent transport of γ2 subunit-containing receptors remain unclear.
PRIP (phospholipase C-related, but catalytically inactive protein), a new molecule implicated in regulating the GABA A -receptor activity Additional evidence for the functional importance of GABARAP in regulating GABA A -receptor trafficking came from our gene targeting studies of PRIP. PRIP was originally isolated as a novel D-myo-inositol 1,4,5-trisphosphate binding protein with a domain organization similar to phospholipase C-δ but lacking enzymatic activity (13 -15) . Later, PRIP was identified as a molecule that binds to GABARAP and inhibits the association of GABARAP with the γ2-subunit (16). The PRIP family consists of at least two types of proteins, PRIP-1 and PRIP-2. PRIP-1 is expressed predominantly in the central nervous system, while PRIP-2 shows broad tissue distribution, including in the brain (for review, see ref. 17 ). The region of GABARAP responsible for binding to the intracellular loop of the γ2 subunit is amino acid residues 35 -52, which is shared by PRIP, indicating the competition for the γ2 subunit (16) . Furthermore, PRIP directly binds to the intracellular loop of GABA A -receptor β subunits (18) , the catalytic subunit of protein phosphatase 1 (PP1c) (19) , and protein phosphatase 2A (PP2A) (20) . These binding partners and their functions further support the notion that PRIP, as a receptor subunit intracellular loopassociated protein, in collaboration with the abovementioned molecules, plays an important role in the receptor signaling, particularly in GABARAP-and phosphorylation-dependent GABA A -receptor modulation.
To examine the possible roles of the interaction of PRIP with GABARAP and GABA A -receptor β subunits in the regulation of the receptor function, we generated PRIP-1 and -2 double knockout (PRIP-DKO) mice and analyzed their electrophysiological and behavioral features in combination with the effects of BZ (16, 21) . The GABA A receptor-mediated Cl − current (I GABA ) in freshly isolated hippocampal CA1 cells from wild-type (WT) and PRIP-DKO mice showed little difference in terms of the dose-response relationship; however, there appeared to be some dysfunction in BZ action. Diazepam, a typical BZ-type drug, reversibly potentiated I GABA elicited by GABA in a dose-dependent manner in neurons from WT mice. In contrast, the potentiation of I GABA was markedly reduced in neurons from PRIP-DKO mice. Behavioral analysis also supported the results obtained by electrophysiological analysis. The elevated plus maze test was performed to examine the anxiolytic effects of diazepam on WT and PRIP-DKO mice. No significant difference in the time spent in the open or closed arms of the maze was apparent between WT and PRIP-DKO mice injected with vehicle. However, a clear difference was observed when mice were injected with diazepam: injection into WT mice resulted in a marked increase in the time spent in the open arm, indicative of the anti-anxiety effect of this drug. In contrast, the time that PRIP-DKO mice spent in the open arm was not affected. These results clearly showed reduced sensitivity to diazepam in PRIP-DKO mice, probably caused by the reduced number of γ2 subunitcontaining receptors on the cell surface membrane. In agreement with this, a ligand-binding assay using [
3 H]flumazenil, a BZ-drug antagonist, confirmed the reduced expression of diazepam-sensitive GABA A receptors with the upregulation of muscimol binding (total GABA A -receptor number) on the cell surface.
As described above, studies of PRIP were initiated based on the finding that PRIP interacts with GABARAP in a competitive manner with the γ2 subunit of GABA A receptors. On the basis of the finding that GABARAP facilitates the membrane transport of γ2 subunit-containing receptors to the cell surface (8, 9) , it was first predicted that the gene knockout of PRIP-1 and -2, which would eliminate PRIP-dependent competition of GABARAP binding to GABA A receptors, would result in an increased cell surface expression of γ2 subunit-containing receptors. However, the results obtained were the opposite (we called this "the γ-paradox").
In an attempt to resolve the γ-paradox, we focused on characterizing the direct interaction of PRIP with the β subunits of GABA A receptors. The region responsible for the interaction was recently mapped (amino acid residues 544 -568 of rat PRIP-1) and is located remote from the binding region of GABARAP (20) . Therefore, we confirmed that ternary complex formation can occur among the receptor β subunit, PRIP-1, and GABARAP. Furthermore, disruption of this direct interaction by an interference peptide (mimicking the β subunit binding region of PRIP) inhibited cell-surface expression of γ2 subunit-containing GABA A receptors in rat hippocampal cells, which resembled the phenotype of PRIP-DKO mice. Considering these results, we propose that the formation of trimeric complexes among the β subunits, GABARAP, and PRIP would facilitate the association of GABARAP with the γ2 subunit, so that it would be transported at the right place at the right time (see Fig. 2 ), or an association between the β-subunits and PRIP would promote the association between the γ2 subunit and GABARAP, and thus facilitate the cell surface expression of the γ2 subunit-containing GABA A receptors; however, the precise molecular mechanisms remain to be elucidated.
Regulation of GABA A receptor endocytosis
Receptor endocytosis appears to regulate the cell surface expression of neurotransmitter receptors, and such regulation is an important mechanism for controlling synaptic strength. This is one of the mechanisms of the modulation of GABAergic transmission. There are ample studies showing that GABA A receptors are constitutively endocytosed, followed by either recycling back to the surface membrane or lysosomal degradation (for review, see ref. 22 ). It has also been found that extracellular signal-mediated endocytosis occurs: the rapid down-regulation of GABA A receptors by brainderived neurotrophic factor (BDNF) is a relatively wellstudied example.
BDNF, one of the neurotrophins secreted from both neurons and glia, is involved in the regulation of neuron survival and differentiation during development as slow or long-term effects, or the synaptic transmission and plasticity in the adult nervous system as rapid or shortterm effects. Acting via the TrkB tyrosine kinase receptor, both effects of BDNF might share the same underlying signaling mechanisms: that is, the activation of receptor tyrosine kinase upon ligand binding, which would be followed by activations of serine / threonine kinases, including protein kinase C (PKC) via some adaptor or scaffolding proteins, and then probably further effects on gene-expression systems and more in the case of slow effects. BDNF exerts rapid effects on synaptic transmission both presynaptically, by modulating transmitter release, and postsynaptically, by chang- Fig. 2 . Trafficking of GABAA receptors to the cell surface. The trafficking of GABAA receptors within the secretory pathway is facilitated by GABARAP, which binds directly to γ2 subunits regulating the delivery of γ2 subunit-containing receptors to the cell surface membrane. PRIP might be involved in these processes by regulating the function of GABARAP (for details, see the text).
ing the properties of ionotropic receptors. At inhibitory synapses, the application of BDNF acutely depresses inhibitory synaptic transmission mediated through GABA A receptors in hippocampal slices (23) and reduces miniature inhibitory postsynaptic currents (mIPSC) in cultured hippocampal (24) and cerebellar granule (25) neurons, or it induces long-lasting depression of mIPSC with a transient early enhancement in cultured hippocampal neurons (26) . These effects were revealed to occur predominantly at postsynaptic sites in mouse cerebellar granule neurons (25) and were confirmed in superior colliculus neurons using BDNF knockout mice (27) . Regarding the mechanisms responsible for the BDNF-induced down regulation, reduced synaptic inhibitory activity in rat hippocampal pyramidal cells by BDNF is associated with a rapid and lasting reduction of the number of GABA A receptors containing α2, β2 or β3, and γ2 subunits, as assessed by immunofluorescence studies (24) . Similar effects (reduced immunoreactivity of β2/ 3 subunits) were observed with mouse cerebellar granule neurons (25) , suggesting that GABA A -receptor endocytosis is enhanced in response to BDNF application at postsynaptic neurons. Furthermore, Hewitt and Bains reported that the BDNFactivated dynamin-mediated endocytosis of GABA A receptors was observed in the paraventricular nucleus of the hypothalamus parvocellular neurons (28) . In contrast, it was reported that the BDNF-induced apparent reduction of GABAergic mIPSC in cultured hippocampal neurons may be predominantly due to reduced channel activity caused by the phosphorylation of the β3 subunit, not to the decreased number of receptors (26) .
There is accumulating evidence that the activation of PKC caused by BDNF is well correlated with the down regulation of GABA A receptors in recombinant expression systems (for review, see ref. 29 ). For instance, GABA A receptors composed of α1/ β2 / γ2 subunits are internalized in response to the activation of PKC in frog oocytes (30, 31) . In recombinant receptorexpressing human embryonic kidney (HEK) cells, the down regulation of GABAergic transmission induced by activation of PKC is caused by internalization of the receptors (32 -34) . Straightforward interpretation of these observations suggests that the phosphorylation of receptor subunits by PKC might be involved in the internalization of the receptors. However, it is controversial whether the phosphorylation of the receptor subunit itself by PKC is closely related to the receptor internalization. Down regulation of the receptors from the cell surface in HEK293 cells after PKC activation was reported to be independent of receptor subunit phosphorylation, as mutation of the known PKC sites in these receptor subunits does not block internalization (31, 32, 35) , suggesting that the phosphorylation of some molecule(s) participating in endocytotic processes but not the subunit itself, might be of primary importance. We found that BDNF induces a reduction of the surface GABA A -receptor number, as assessed by the [ 3 H]muscimol binding assay using cultured cortical neurons, and this reduction is inversely correlated with the phosphorylation level of the β3 subunits of the receptor: in other words, the de-phosphorylation level of the β3 subunit (20) as assessed by Western blot analysis using anti-phospho(Ser
408/ 409
) specific β3 antibody is well correlated with the decrease of the number of receptors. This was the first report to our knowledge demonstrating that de-phosphorylation of the β subunit appears to be involved in the GABA A -receptor endocytosis process. This finding may be supported by the notion that PKCstimulated endocytosis does not necessarily require receptor phosphorylation in the recombinant expression system using HEK cells (for review, see ref. 22 ).
The molecular basis of GABA A -receptor endocytosis has recently begun to be clarified. The process of the endocytosis of GABA A receptors involves a clathrinmediated dynamin-dependent mechanism in the recombinant expression system in HEK cells (34, 36, 37) . Clathrin-mediated endocytosis is a major vesicular internalization mechanism in eukaryotic cells. The carrier vesicles of this pathway are designated clathrincoated vesicles, and surface receptors destined to be endocytosed are recruited into the clathrin-coated vesicles formed at the plasma membrane. This process is facilitated by the adaptor protein 2 complex (AP2), which consists of two heavy (α and β) adaptin subunits, a medium µ2 subunit and a small σ subunit, and has the bivalent capacity to interact with both cytosolic domains of receptors and clathrin. In addition to the main structural components, clathrin-coated vesicles contain many accessory proteins, including dynamin, participating in cytokinesis. It has been reported that GABA Areceptor β and γ subunits associate with AP2, and therefore recombinant GABA A receptors are constitutively endocytosed (36) . An AP2 adaptin dileucinebinding motif on the GABA A -receptor β subunits was shown to be critical for the receptor endocytosis, and a peptide corresponding to the dileucine motif prevented PKC-mediated GABA A -receptor endocytosis, and the endocytosis was also prevented by the dynamin K44A mutant (34, 37) . Recently, an atypical AP2-binding motif conserved within all β subunits of the GABA A receptor, in which a serine residue that can be phosphorylated is present, was reported to associate with the µ2 subunit of AP2 (38) . Interestingly, the association between the AP2 complex and β subunits is prevented by the phosphorylation of β subunits (i.e., phosphorylation of S409 in β1, S410 in β2, and S408 / S409 in β3 subunits). A phospho-peptide corresponding to the binding motif drastically reduces the affinity of the AP2 complex for GABA A -receptor β subunits and enhances the amplitude of mIPSC (38) , indicating that endocytosis of GABA A receptors is down-regulated by the phosphorylation of β subunits. Consistent with this finding, the phospho-peptide diminishes phosphodependent endocytosis of GABA A receptors in the dopamine D 3 receptor-mediated protein kinase A (PKA)-activated signaling (39) . These observations support our finding: de-phosphorylation of the β3-subunit of the receptor leads to the internalization of the receptor in neurons, probably by facilitating the association with AP2 complex (20) . In contrast to these studies of phosphorylation by kinases, little is known regarding the regulation of receptor de-phosphorylation. Our yeast two-hybrid analysis revealed the association of PRIP with PP1, and we showed that the complex formation makes PP1 catalytically inactive (19) . In PRIP knockout mice, forskolin, a PKA activator, causes less phosphorylation of the β3 subunit than that observed in the wild-type mice, because of the higher phosphatase activity of PP1 in the PRIP knockout neurons (18) . PP2A also associates with PRIP, but the activity is stable irrespective of the association (20) . Since PRIP directly binds to β-subunits of the receptor, PRIP may be involved in the modulation of phosphorylation-dependent GABA A -receptor activity as a scaffold protein of the protein phosphatases.
Evidence of functional regulation by the de-phosphorylation of the β3 subunit of GABA A receptor was obtained in our recent studies (20, 40) . BDNF-mediated down regulation of GABAergic current was completely blocked, and de-phosphorylation of the β3 subunit was not seen in hippocampal neurons prepared from PRIP-DKO mice, whereas the de-phosphorylation was evident in the WT neurons, leading to the internalization of the receptors. The importance of the association between PRIP and the β subunits in this event was tested using the aforementioned interference peptide affecting the binding. The peptide inhibited the BDNF-mediated down regulation of GABAergic current in the WT hippocampal neurons, which resembled the phenotype of PRIP-DKO mice. Therefore, these results suggested that PRIP enhances the de-phosphorylation of GABA Areceptor β subunits by acting as a scaffold protein of the protein phosphatases (PP1 and PP2A) and regulates the phospho-dependent clathrin / AP2-mediated receptor endocytosis (20, 38, 39) . Additionally, the clathrin heavy chain, the µ2 and β2 subunits of AP2, and PRIP-1 were complexed with GABA A receptors in brain extract, as shown by co-immunoprecipitation assays using anti-PRIP-1 and anti-β2 / 3 GABA A -receptor antibody or by pull-down assays using the β subunit of the GABA A receptor (40) . Taking this evidence all together, PRIP is an important component in the phospho-dependent endocytosis process of GABA A receptor that acts to regulate the number of cell surface-expressed receptors and to maintain the strength of inhibitory synapses (Fig. 3) .
Other molecules implicated in GABA A -receptor activities
A variety of proteins that associate with the intracellular loops of GABA A -receptor subunits have been identified (see Fig. 1B and for review, see refs. 2 and 22) . In addition to GABARAP, PRIP, and the µ2 subunit of AP2 (described in this article), the Golgi-specific DHHC zinc finger protein (GODZ), which associates with the γ2 subunits and is also believed to modulate the γ2 subunit-dependent trafficking pathway; the brefeldin A-inhibited GDP / GTP exchange factor 2 (BIG2), which associates with β1 -3 subunits and may be involved in the GABA A -receptor intracellular β subunit-dependent trafficking; Plic-1, which associates with α2, α3, α6, and β1 -3 subunits and facilitates the recycling pathway of the receptor; the huntingtinassociated protein 1 (HAP1), which associates with the β1 subunit of the receptor and may regulate the receptor endocytic sorting pathway; and protein kinases and their interacting proteins, including A-kinase (PKA)-associating protein (AKAP), Src, and the receptor for activated C kinase (RACK1), have also been reported. These proteins share or overlap with the region in the intracellular loop responsible for binding, raising a major question; do GABA A receptors simultaneously form a complex with all these associating proteins? This is probably unlikely because it would lead to a heavy molecular jam causing steric hindrance. Then, how do the neurons select these associations based upon various requirements of themselves? Are there any more proteins associating with the receptor subunits? Much additional research will be needed for a full understanding.
